Palladyne AI Corp. (PDYN) is a U.S. defense and industrial technology company that develops embodied AI software for robotic and autonomous systems. Four current analyst targets were reviewed: Lake Street initiated coverage with a Buy and an $11 target (April 2026); Northland Capital Markets initiated with an Outperform and a $10 target (April 2026); Jefferies maintained a Hold with a $7 target (March 2026); and Alliance Global Partners carried a Buy with a $15 target. Averaging these four figures produces a mean of $10.75, which rounds to the $11 central target used here. The low-to-high range of $7 to $15 is unusually wide and signals real disagreement about execution.
Aggregators generally describe the rating consensus as Buy or Moderate Buy, driven by three bullish ratings and one Hold. Bullish analysts emphasize the defense-autonomy opportunity, contract momentum, and a strengthening backlog. The more cautious Hold view reflects the fact that the business is not yet profitable and that commercialization remains early. Notably, most of these targets were set before the stock's recent slide, meaning they now imply far larger upside than when they were published. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The stock closed near $3.54 on November 9, 2026, near the low end of a 52-week range of $2.66 to $10.00, with a market capitalization of roughly $150 million. From $3.54, the $11 target requires about a 210% gain, which by any standard is a very large move rather than a modest or incremental one.
The fundamentals show a company scaling quickly but still losing money. Trailing-twelve-month revenue was about $11.84 million against a net loss near $30 million, with diluted EPS (earnings per share) of roughly -$0.69 and a price-to-sales ratio around 11.5x. The company has guided to 2026 revenue of $24 million to $27 million, which would mark substantial growth. Reaching $11 would likely require converting that growth into sustained contract wins, expanding gross margins, and giving investors a credible path toward profitability, not just revenue expansion.
Palladyne AI operates at the intersection of artificial intelligence, robotics, and defense, a segment benefiting from strong demand for autonomous systems. Its pipeline includes the Palladyne IQ and Pilot software platforms, the SwarmOS autonomy stack, and the BRAIN edge AI flight computer. The company has announced contracts and milestones with the U.S. Air Force, Army, and Navy, as well as partnerships with Red Cat, Israel Aerospace Industries, FANUC America, and a SwarmShot counter-drone collaboration with Federal Ammunition and Mossberg. A backlog of roughly $24 million and second-quarter 2026 revenue growth of about 470% year over year underscore the scaling story underpinning the bullish targets.
The principal obstacle is profitability. Despite rapid top-line growth, the company continues to post significant net losses and negative free cash flow, supported by about $43.75 million in cash. Sustained losses raise the risk of future dilution, which would pressure the share count and the stock price. Revenue also depends heavily on government and defense customers, whose contract timing and budgets can be unpredictable. Competition in the defense-autonomy and drone-software space is intense, and a high price-to-sales multiple leaves little room for execution missteps. Insider selling reported in recent quarters has added another cautionary signal for some investors.
The chart context matters. The stock's prior high near $10, reached earlier in 2026, now functions as a major resistance zone, and the $11 target sits just above it. A sustained move toward the target would first need to reclaim that prior high. On the downside, the recent 52-week low near $2.66 is a key support level. The stock currently trades below both its 50-day and 200-day moving averages, indicating a longer-term downtrend that would need to reverse before any approach to $11 becomes technically credible.
Analyst price targets typically reflect a roughly 12-month research horizon, though the exact horizon varies by firm and is not always disclosed. Key items to monitor include the fiscal third-quarter 2026 earnings report, updated revenue guidance, new contract announcements, and any analyst revisions or target changes. Defense budget developments, interest-rate expectations, and the broader performance of small-cap growth and AI stocks are also relevant to sentiment. None of these factors guarantees a move toward $11, but they will shape the debate. From what I see, this is important because the timing of those catalysts will determine whether the wide target range narrows or expands.
I often turn to Tickeron’s AI Daily Buy/Sell Signals when evaluating names like PDYN. The tool applies artificial intelligence to scan thousands of stocks and ETFs in real time, producing Buy, Sell, or Hold signals based on technical patterns, market conditions, and momentum shifts. It helps me cross-check fundamental views with a systematic layer, especially useful for smaller-cap defense and autonomy plays where sentiment can change quickly. Investors can combine these signals with their own analysis to stay current on potential turning points.
The $11 target is a rounded average of four analyst price targets spanning $7 to $15, and it implies a move of roughly 210% from the recent price near $3.54. The bull case rests on fast-growing defense-autonomy revenue, a strengthening backlog, and high-profile partnerships, while the bear case centers on continued losses, cash burn, and heavy reliance on government contracts. The wide analyst range and the stock's position below its prior high near $10 underscore that this is a high-risk, high-reward scenario. Whether PDYN can reach $11 depends on sustained revenue execution and a credible path to profitability, not on any single catalyst, and no outcome is guaranteed.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The RSI Oscillator for PDYN moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 27 of the 30 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for PDYN just turned positive on November 09, 2026. Looking at past instances where PDYN's MACD turned positive, the stock continued to rise in 46 of 52 cases over the following month. The odds of a continued upward trend are 88%.
Following a +30.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where PDYN advanced for three days, in 203 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
PDYN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PDYN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for PDYN entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.103) is normal, around the industry mean (16.272). P/E Ratio (-4.254) is within average values for comparable stocks, (52.956). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.430) among similar stocks. P/S Ratio (21.413) is also within normal values, averaging (103.889).
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. PDYN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PDYN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications